[Mechanism and overcome against drug resistance to imatinib for treatment of chronic myeloid leukemia]. [electronic resource]
Producer: 20110701Description: 749-53 p. digitalISSN:- 0385-0684
- Antineoplastic Agents -- therapeutic use
- Benzamides
- Drug Resistance, Neoplasm
- Fusion Proteins, bcr-abl -- genetics
- Humans
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Organic Cation Transporter 1 -- metabolism
- Piperazines -- therapeutic use
- Pyrimidines -- therapeutic use
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.